Literature DB >> 22589603

Insulin sensitivity and secretory status of a healthy malay population.

Abu Kholdun Al-Mahmood1, Aziz Al-Safi Ismail, Faridah Abdul Rashid, Wan Mohamad Wan Bebakar.   

Abstract

Insulin insensitivity is a common finding in several metabolic disorders including glucose intolerance, dyslipidemia, hyperuricemia and hypertension. Most of the previous studies on insulin sensitivity were performed on diabetic or obese population. So our knowledge about insulin sensitivity of healthy population remains limited. Rising prevalence of obesity, diabetes and metabolic syndrome is a serious issue in Malaysia and some other rapidly developing countries. So it is important to look at the insulin sensitivity status of healthy Malaysian subjects and to compare it in future with those of diabetic, obese or metabolic syndrome patients. In this study we sampled subjects who were independent of confounding factors such as obesity (including abdominal obesity), hypertension and glucose intolerance (diabetes, IGT or IFG) which may influence insulin sensitivity. Fasting plasma glucose, fasting insulin and lipid profile were determined. Insulin sensitivity and secretory status were calculated using the homeostasis model assessment (HOMA) software (HOMA%S, HOMA%B and HOMA-IR). The insulin sensitivity (HOMA%S) of healthy Malay subjects aged between 30-60 years was 155.17%, HOMA-IR was 1.05 and HOMA%B was 116.65% (values adjusted for age, sex, BMI and waist circumference). It was seen that non-obese Malaysians can prevent age related lowering of insulin sensitivity if they can retain their BMI within limit.

Entities:  

Keywords:  homeostasis model assessment; insulin sensitivity

Year:  2006        PMID: 22589603      PMCID: PMC3349483     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  25 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Pathogenesis of type 2 diabetes. Insulin resistance.

Authors:  G Boden
Journal:  Endocrinol Metab Clin North Am       Date:  2001-12       Impact factor: 4.741

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 5.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.

Authors:  J P Hosker; A S Rudenski; M A Burnett; D R Matthews; R C Turner
Journal:  Metabolism       Date:  1989-08       Impact factor: 8.694

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes.

Authors:  A S Rudenski; D R Matthews; J C Levy; R C Turner
Journal:  Metabolism       Date:  1991-09       Impact factor: 8.694

10.  Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

Authors:  M Chen; R N Bergman; G Pacini; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

View more
  4 in total

1.  Evaluating Vitamin D Status in Pre- and Postmenopausal Type 2 Diabetics and Its Association with Glucose Homeostasis.

Authors:  Linda Ahenkorah Fondjo; Samuel Asamoah Sakyi; William K B A Owiredu; Edwin Ferguson Laing; Eddie-Williams Owiredu; Ebenezer Kwesi Awusi; Richard K D Ephraim; Osei Sarfo Kantanka
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

2.  An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques.

Authors:  Armin Mooranian; Nassim Zamani; Ryu Takechi; Giuseppe Luna; Momir Mikov; Svetlana Goločorbin-Kon; Magdy Elnashar; Frank Arfuso; Hani Al-Salami
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

3.  The dysregulation of the hypothalamic-pituitary-adrenal axis in diet-induced prediabetic male Sprague Dawley rats.

Authors:  Palesa Mosili; Bongeka Cassandra Mkhize; Phikelelani Ngubane; Ntethelelo Sibiya; Andile Khathi
Journal:  Nutr Metab (Lond)       Date:  2020-12-11       Impact factor: 4.169

4.  Pretransplant HOMA-β Is Predictive of Insulin Independence in 7 Patients With Chronic Pancreatitis Undergoing Islet Autotransplantation.

Authors:  Christine A Beamish; A Osama Gaber; Daniel W Fraga; Dale J Hamilton; Omaima M Sabek
Journal:  Transplant Direct       Date:  2022-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.